M. Lagget

714 total citations
27 papers, 516 citations indexed

About

M. Lagget is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, M. Lagget has authored 27 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in M. Lagget's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (12 papers). M. Lagget is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (12 papers). M. Lagget collaborates with scholars based in Italy, United States and Germany. M. Lagget's co-authors include Mario Rizzetto, Antonina Smedile, Alfredo Marzano, Mario Rizzetto, Alessia Ciancio, Antonella Olivero, Giovanni C. Actis, Grazia Anna Niro, Silvia Gaia and Michael P. Manns and has published in prestigious journals such as Hepatology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

M. Lagget

27 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Lagget Italy 14 424 381 51 50 47 27 516
Elisa Bartolini Italy 13 294 0.7× 172 0.5× 21 0.4× 11 0.2× 29 0.6× 28 443
Tanju Özkan Türkiye 11 165 0.4× 119 0.3× 41 0.8× 89 1.8× 36 0.8× 29 372
R. Cuppone Italy 9 199 0.5× 192 0.5× 20 0.4× 26 0.5× 14 0.3× 17 301
Bülent Değertekın Türkiye 12 411 1.0× 336 0.9× 71 1.4× 54 1.1× 18 0.4× 25 519
Kubilay Çınar Türkiye 13 253 0.6× 248 0.7× 48 0.9× 93 1.9× 8 0.2× 38 441
Giuseppe Barbaro Italy 8 261 0.6× 245 0.6× 62 1.2× 11 0.2× 7 0.1× 9 356
D Galmarini Italy 11 266 0.6× 350 0.9× 19 0.4× 193 3.9× 15 0.3× 58 487
Fatih Karakaya Türkiye 9 331 0.8× 288 0.8× 34 0.7× 51 1.0× 8 0.2× 26 411
Adam Herber Germany 10 114 0.3× 93 0.2× 46 0.9× 57 1.1× 44 0.9× 23 282
Dominic Dell Olio Italy 9 122 0.3× 177 0.5× 24 0.5× 107 2.1× 24 0.5× 18 312

Countries citing papers authored by M. Lagget

Since Specialization
Citations

This map shows the geographic impact of M. Lagget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lagget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lagget more than expected).

Fields of papers citing papers by M. Lagget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lagget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lagget. The network helps show where M. Lagget may publish in the future.

Co-authorship network of co-authors of M. Lagget

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lagget. A scholar is included among the top collaborators of M. Lagget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lagget. M. Lagget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaia, Silvia, Antonina Smedile, Antonella Olivero, et al.. (2008). Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine. Journal of Hepatology. 48(4). 540–547. 34 indexed citations
2.
Gaia, Silvia, S. Carenzi, F. Brunello, et al.. (2008). Is liver stiffness measurement different in patients with NASH or with viral hepatitis?. Digestive and Liver Disease. 40(10). A128–A128. 6 indexed citations
3.
Actis, Giovanni C., et al.. (2007). The Practice of Percutaneous Liver Biopsy in a Gastrohepatology Day Hospital: A Retrospective Study on 835 Biopsies. Digestive Diseases and Sciences. 52(10). 2576–2579. 28 indexed citations
4.
Gaia, Silvia, S. Carenzi, F. Brunello, et al.. (2007). [712] IS LIVER STIFFNESS MEASUREMENT DIFFERENT IN PATIENTS WITH NASH OR WITH VIRAL HEPATITIS?. Journal of Hepatology. 46. S268–S269. 2 indexed citations
5.
Pellicano, Rinaldo, R Bonardi, Antonina Smedile, et al.. (2007). [Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report].. PubMed. 98(1). 19–23. 7 indexed citations
6.
Niro, Grazia Anna, Alessia Ciancio, M. Lagget, et al.. (2005). Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study. Alimentary Pharmacology & Therapeutics. 22(3). 227–232. 89 indexed citations
7.
Gaia, Silvia, Alfredo Marzano, Antonina Smedile, et al.. (2004). Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen‐negative chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 20(3). 281–287. 30 indexed citations
8.
Ciancio, Alessia, Antonina Smedile, Mario Rizzetto, et al.. (2004). Identification of HBV DNA sequences that are predictive of response to lamivudine therapy. Hepatology. 39(1). 64–73. 34 indexed citations
9.
Rizzetto, Mario, Robert Goldin, Rafael Esteban, et al.. (2004). Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. Journal of Hepatology. 42(2). 173–179. 66 indexed citations
10.
Lagget, M., et al.. (2004). Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis.. PubMed. 95(1). 65–70. 13 indexed citations
11.
Lagget, M. & Mario Rizzetto. (2003). Current pharmacotherapy for the treatment of chronic hepatitis B. Expert Opinion on Pharmacotherapy. 4(10). 1821–1827. 14 indexed citations
12.
Niro, Grazia Anna, M. Lagget, Hans L. Tillmann, et al.. (2003). Efficacy of lamivudine therapy in chronic delta hepatitis: A multicenter randomized controlled pilot study. Journal of Hepatology. 38. 159–159. 4 indexed citations
13.
Arese, Paolo, Giovanni C. Actis, M. Lagget, et al.. (2000). Severe steroid-unresponsive ulcerative colitis. Diseases of the Colon & Rectum. 43(5). 609–613. 28 indexed citations
14.
Keller, Roberto, Riccardo Torta, M. Lagget, S. Crasto, & B. Bergamasco. (1999). Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment. The Italian Journal of Neurological Sciences. 20(1). 49–54. 37 indexed citations
15.
Lagget, M., Alfredo Marzano, Giovanni C. Actis, et al.. (1998). Disappearance of diabetes mellitus after conversion from fk 506 to neoral in two liver transplanted patients. Transplantation Proceedings. 30(5). 1863–1864. 5 indexed citations
16.
Borghesio, E., F. Rosina, Antonina Smedile, et al.. (1998). Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation. Hepatology. 27(3). 873–876. 27 indexed citations
17.
Rosina, F., Gregory J. Della Rocca, Bruna Lavezzo, et al.. (1996). Effect of patient characteristics on hospital costs for cirrhosis: implications for the disease-related group (DRG) reimbursement system.. PubMed. 28(7). 401–5. 10 indexed citations
18.
Actis, Giovanni C., W. Debernardi‐Venon, M. Lagget, et al.. (1995). Hepatotoxicity of intravenous Cyclosporin A in patients with acute ulcerative colitis on total parenteral nutrition. Liver International. 15(6). 320–323. 20 indexed citations
19.
Actis, Giovanni C., et al.. (1995). Recurrent Sweetʼs Syndrome in Reactivated Crohnʼs Disease. Journal of Clinical Gastroenterology. 21(4). 317–319. 16 indexed citations
20.
Marzano, Alfredo, Antonina Smedile, A. Ottobrelli, et al.. (1994). Hepatitis type C after ortothopic liver transplantation: reinfection and disease recurrence. Journal of Hepatology. 21(6). 961–965. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026